CenterStar Asset Management’s Microsoft MSFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.58M Sell
6,919
-2,768
-29% -$1.12M 0.44% 44
2026
Q1
$3.58M Buy
9,687
+7,947
+457% +$3.33M 0.45% 41
2025
Q4
$842K Buy
1,740
+956
+122% +$479K 0.24% 101
2025
Q3
$406K Buy
+784
New +$400K 0.09% 192
2025
Q2
Sell
-1,237
Closed -$537K 329
2025
Q1
$465K Buy
+1,237
New +$504K 0.11% 210
2024
Q3
Sell
-903
Closed -$386K 364
2024
Q2
$405K Sell
903
-112
-11% -$47.3K 0.11% 170
2024
Q1
$428K Buy
+1,015
New +$411K 0.13% 160
2023
Q3
Sell
-3,919
Closed -$1.33M 416
2023
Q2
$1.33M Buy
+3,919
New +$1.23M 0.15% 88
2022
Q4
Hold
0
30
2022
Q3
Hold
0
154
2022
Q2
Hold
0
75
2021
Q4
Hold
0
144
2021
Q3
Hold
0
108
2021
Q2
Hold
0
265
2021
Q1
Hold
0
115
2020
Q4
Hold
0
111
2020
Q2
Hold
0
500
2019
Q2
Hold
0
49
2018
Q4
Hold
0
48
2018
Q3
Hold
0
44
2018
Q1
Hold
0
54

Other funds holding MSFT

CenterStar Asset Management's MSFT Position: Q2 2026 in Review

CenterStar Asset Management reduced its Microsoft (MSFT) stake by 29% in Q2 2026, selling an estimated $1.12M and leaving 6,919 shares worth $2.58M. The position accounts for 0.44% of the portfolio, ranked #44.

CenterStar Asset Management first reported a position in MSFT in Q2 2023 and has held it in 8 quarters since. The position peaked at $3.58M in Q1 2026. 6,241 funds tracked by Wall St. Rank hold MSFT as of Q2 2026.

  • CenterStar Asset Management held 6,919 shares of Microsoft worth $2.58M as of Q2 2026.
  • CenterStar Asset Management sold 2,768 Microsoft shares in Q2 2026, an estimated $1.12M.
  • Microsoft made up 0.44% of CenterStar Asset Management's portfolio in Q2 2026, its #44 holding.
  • CenterStar Asset Management first reported a position in Microsoft in Q2 2023 and has held it in 8 quarters since.
  • CenterStar Asset Management's Microsoft position peaked at $3.58M in Q1 2026.
  • 6,241 funds tracked by Wall St. Rank held Microsoft as of Q2 2026.

Based on CenterStar Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.